Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser

Tierney, Emily; Hanke, C. William

doi:10.1002/lsm.20811

Cited by 35 publications

(38 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Facial telangiectasia and diffuse facial erythema Recommendation 7: We recommend the use of lasers and IPLS for treatment of facial telangiectasia and diffuse facial erythema (GRADE 1A). 2,[51][52][53][54][55][56] Facial telangiectasias are common cause of cosmetic concern. Among available treatment modalities (electrosurgery, lasers and light sources) the latter two are considered both safe and effective.…”

Section: Treatment Of Different Vascular Lesionsmentioning

confidence: 99%

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Adamič¹,

Pavlović

Rubin

et al. 2015

Acad Dermatol Venereol

View full text Add to dashboard Cite

Aim Lasers and non-coherent intense pulse light sources (IPLS) are based on the principle of selective photothermolysis and can be used for the treatment of many vascular skin lesions. A variety of lasers has been developed for the treatment of congenital and acquired vascular lesions which incorporate these concepts into their design. Although laser and light sources are very popular due to their non-invasive nature, caution should be considered by practitioners and patients to avoid permanent side-effects. The aim of these guidelines is to give evidence-based recommendations for the use of lasers and IPLS in the treatment of vascular lesions. Results Lasers and IPLS are very useful and sometimes the only available method to treat various vascular lesions. It is of a paramount importance that the type of laser or IPLS and their specific parameters are adapted to the indication but also that the treating physician is familiar with the device to be used. The crucial issue in treating vascular lesions is to recognize the immediate end-point after laser treatment. This is the single most important factor to ensure both the efficacy of the treatment and avoidance of serious side-effects. Methods Conflicts of interestNone declared. Funding sourceNone.Since the publication of previous European Society of Laser Dermatology (ESLD) guidelines in 2007, there have been significant advances in the field of laser treatment of common vascular lesions.1 These guidelines have been updated by the Consensus Panel under the auspices of the ESLD. Methodology, search strategy and recommendation formulation are described in Appendix II. A brief overview of vascular lasersStandard vascular lasers include pulsed dye lasers (585 and 595 nm), and KTP-lasers (532 nm), followed by longer wavelength lasers such as alexandrite lasers (755 nm), diode lasers (800-900 nm) and millisecond Nd:YAG lasers (1064 nm). New developments include a non-uniform pulse sequence or a dual-wavelength modality (combined dual wavelength 595 and 1064 nm-pulsed dye and Nd:YAG laser) and microsecond Nd: YAG lasers. [2][3][4][5][6] Even fractional photothermolysis has begun to be used for selected vascular lesions. Lasers' and intense pulse light sources (IPLS) effects are based on the principle of selective photothermolysis. In general, they deliver a precisely graded aliquot of energy to a defined area of the skin in a reproducible, standardized manner that almost always involves addition or evacuation of heat. The greatestThe first two authors have contributed equally to the manuscript.

show abstract

Section: Treatment Of Different Vascular Lesionsmentioning

confidence: 99%

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Adamič¹,

Pavlović

Rubin

et al. 2015

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…Telangiectasias are one of the most common reasons people seek cosmetic laser treatment. Facial telangiectasias have been estimated to affect millions of people worldwide 6. Telangiectasias are defined as dilated blood vessels with a diameter of 0.1–1.0 mm and can be classified into four main types: simple (linear), arborizing, spider, and punctate 7.…”

Section: Discussionmentioning

confidence: 99%

When not to treat cutaneous vascular lesions with the pulsed dye laser

et al. 2011

View full text Add to dashboard Cite

The availability of effective laser treatment for cutaneous vascular lesions has risen dramatically in recent years. At the same time, there has been a proliferation of laser providers with varying amounts of training-both medical and nonmedical. We report a series of four cases where patients presented for cosmetic evaluation of vascular lesions and were discovered to have more significant pathologic disease. In presenting these cases, we hope to illuminate a basic differential diagnosis that exists for cutaneous vascular lesions and remind healthcare providers that not all "cosmetic" concerns are benign in origin. There is a differential diagnosis that exists for cutaneous vascular lesions that is worth reviewing, and it should be considered in all patients presenting for laser treatment.

show abstract

“…Diode lasers may be used in up to Type IV Fitzpatrick skin and have limited usage in darker skin types. Diode lasers have a well-known usage in the treatment of unwanted hair; however, they may also be effective in the treatment of facial ectasias [6,12,16]. In a study by Tierney et al [6], they performed a randomized blinded split faced trial comparing 532 nm and 940 nm diode laser wavelengths.…”

Section: Neodymium-doped Yttriummentioning

confidence: 98%

“…color and darker, this is due to thrombus formation and vessel damage. Patients should practice photo protection with appropriate sunscreens with SPF 30 or greater, avoid trauma, and cigarette smoking [5,6]. Uelbohoer et al [7] performed a split face comparison of KTP and PDL for the treatment of telangiectasias and facial erythema in 15 subjects.…”

Section: Potassium Titanyl Phosphate (532 Nm Green) Lasermentioning

confidence: 99%

Laser Treatment of Telangiectasias

Brown

Goldberg

2011

Aesthetic Medicine

View full text Add to dashboard Cite

Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser

Abstract: While both 532 and 940 nm diode laser produced significant improvement in facial telangiectasias, greater efficacy was found with 940 nm as well as a significantly more tolerable side effect profile. Lasers Surg. Med. 41:555-562, 2009. (c) 2009 Wiley-Liss, Inc.

Cited by 35 publications

References 18 publications

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

When not to treat cutaneous vascular lesions with the pulsed dye laser

Laser Treatment of Telangiectasias

Contact Info

Product

Resources

About